Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization.

导出 OA

翻译打印收藏纠错

作者： Vadim,Le Joncour ^[1] ; Pauliina,Filppu ^[1] ; Maija,Hyvönen ^[1] ; Minna,Holopainen ^[2] ; S Pauliina,Turunen ^[3] ; Harri,Sihto ^[4] ; Isabel,Burghardt ^[1] ; Heikki,Joensuu ^[5] ; Olli,Tynninen ^[1] ; Juha,Jääskeläinen ^[6] ; Michael,Weller ^[7] ; Kaisa,Lehti ^[8] ; Reijo,Käkelä ^[5] ; Pirjo,Laakkonen ^[3]

作者单位： Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. ^[1] Helsinki University Lipidomics Unit, Helsinki Institute of Life Science (HiLIFE) and Molecular and Integrative Biosciences Research Programme, University of Helsinki, Helsinki, Finland. ^[2] Research Programs Unit, Genome-Scale Biology, University of Helsinki, Helsinki, Finland. ^[3] Department of Microbiology, Tumour and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden. ^[4] Department of Neurology and Brain Tumour Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland. ^[5] Department of Oncology, Helsinki University Hospital, Helsinki, Finland. ^[6] Department of Pathology, Haartman Institute, University of Helsinki and HUSLAB, Helsinki, Finland. ^[7] Kuopio University Hospital, Kuopio, Finland. ^[8] Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland Pirjo.laakkonen@helsinki.fi. ^[9] Laboratory Animal Centre, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland. ^[10]

关键词 LMP MDGI PUFA antihistamine glioma